HEADER TRANSCRIPTION 05-JUL-20 7CHG OBSLTE 14-JUN-23 7CHG 7YFK TITLE THE STRUCTURE OF HUMAN PREGNANE X RECEPTOR IN COMPLEX WITH AN SRC-1 TITLE 2 COACTIVATOR PEPTIDE AND A LIMONOID COMPOUND COMPND MOL_ID: 1; COMPND 2 MOLECULE: NUCLEAR RECEPTOR SUBFAMILY 1 GROUP I MEMBER 2,NUCLEAR COMPND 3 RECEPTOR COACTIVATOR 1; COMPND 4 CHAIN: A, B; COMPND 5 SYNONYM: ORPHAN NUCLEAR RECEPTOR PAR1,ORPHAN NUCLEAR RECEPTOR PXR, COMPND 6 PREGNANE X RECEPTOR,STEROID AND XENOBIOTIC RECEPTOR,SXR,NCOA-1,CLASS COMPND 7 E BASIC HELIX-LOOP-HELIX PROTEIN 74,BHLHE74,PROTEIN HIN-2,RIP160, COMPND 8 RENAL CARCINOMA ANTIGEN NY-REN-52,STEROID RECEPTOR COACTIVATOR 1,SRC- COMPND 9 1; COMPND 10 EC: 2.3.1.48; COMPND 11 ENGINEERED: YES; COMPND 12 OTHER_DETAILS: RESIDUE 130-434 OF HUMAN PXR PROTEIN FUSED WITH COMPND 13 RESIDUES 676-700 OF NCOAI AT C-TERMINAL OF PXR AND SPACED WITH COMPND 14 SSSGGT. SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: NR1I2, PXR, NCOA1, BHLHE74, SRC1; SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 7108 KEYWDS COMPLEX, ACTIVATOR, TRANSCRIPTION, DRUG BINDING, NUCLEAR RECEPTOR EXPDTA X-RAY DIFFRACTION AUTHOR Y.XIA,D.YAO,C.HUANG,Y.CAO REVDAT 2 14-JUN-23 7CHG 1 OBSLTE REVDAT 1 07-JUL-21 7CHG 0 JRNL AUTH Y.XIA,D.YAO,C.HUANG,Y.CAO JRNL TITL THE STRUCTURE OF HUMAN PREGNANE X RECEPTOR IN COMPLEX WITH JRNL TITL 2 AN SRC-1 COACTIVATOR PEPTIDE AND A LIMONOID COMPOUND JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 1.93 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX V1.13 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.93 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 26.59 REMARK 3 MIN(FOBS/SIGMA_FOBS) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 98.8 REMARK 3 NUMBER OF REFLECTIONS : 61015 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.213 REMARK 3 R VALUE (WORKING SET) : 0.212 REMARK 3 FREE R VALUE : 0.250 REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : NULL REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 SOLVENT RADIUS : NULL REMARK 3 SHRINKAGE RADIUS : NULL REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : NULL REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : NULL REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 53.52 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : NULL NULL REMARK 3 ANGLE : NULL NULL REMARK 3 CHIRALITY : NULL NULL REMARK 3 PLANARITY : NULL NULL REMARK 3 DIHEDRAL : NULL NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 7CHG COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 21-JUL-20. REMARK 100 THE DEPOSITION ID IS D_1300017618. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 17-JUN-18 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 8.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SSRF REMARK 200 BEAMLINE : BL19U1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97890 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS3 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 61472 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.930 REMARK 200 RESOLUTION RANGE LOW (A) : 30.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 200 DATA REDUNDANCY : 12.60 REMARK 200 R MERGE (I) : 0.07600 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 4.5000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.95 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.98 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.3 REMARK 200 DATA REDUNDANCY IN SHELL : 6.80 REMARK 200 R MERGE FOR SHELL (I) : 2.10600 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHENIX REMARK 200 STARTING MODEL: 5X0R REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 53.38 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.64 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 10% (V/V) 2-PROPANOL, 100MM IMIDAZOLE/ REMARK 280 HYDROCHLORIC ACID, PH 8.0, EVAPORATION, TEMPERATURE 277.15K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 42.46500 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 53.17050 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 45.05450 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 53.17050 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 42.46500 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 45.05450 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 1870 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 26840 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -16.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 129 REMARK 465 SER A 130 REMARK 465 GLU A 131 REMARK 465 ARG A 132 REMARK 465 THR A 133 REMARK 465 GLY A 134 REMARK 465 THR A 135 REMARK 465 GLN A 136 REMARK 465 PRO A 137 REMARK 465 LEU A 138 REMARK 465 GLY A 139 REMARK 465 VAL A 140 REMARK 465 GLN A 141 REMARK 465 LEU A 178 REMARK 465 SER A 179 REMARK 465 SER A 180 REMARK 465 GLY A 181 REMARK 465 CYS A 182 REMARK 465 GLU A 183 REMARK 465 LEU A 184 REMARK 465 PRO A 185 REMARK 465 GLU A 186 REMARK 465 SER A 187 REMARK 465 LEU A 188 REMARK 465 GLN A 189 REMARK 465 ALA A 190 REMARK 465 PRO A 191 REMARK 465 SER A 192 REMARK 465 ASP A 310 REMARK 465 THR A 311 REMARK 465 ALA A 312 REMARK 465 GLY A 313 REMARK 465 GLY A 314 REMARK 465 PHE A 315 REMARK 465 GLN A 316 REMARK 465 GLN A 317 REMARK 465 GLY A 433 REMARK 465 SER A 434 REMARK 465 SER A 435 REMARK 465 SER A 436 REMARK 465 SER A 437 REMARK 465 GLY A 438 REMARK 465 GLY A 439 REMARK 465 THR A 440 REMARK 465 CYS A 441 REMARK 465 PRO A 442 REMARK 465 SER A 443 REMARK 465 SER A 444 REMARK 465 HIS A 445 REMARK 465 SER A 446 REMARK 465 GLU A 461 REMARK 465 GLY A 462 REMARK 465 SER A 463 REMARK 465 PRO A 464 REMARK 465 SER A 465 REMARK 465 MET B 129 REMARK 465 SER B 130 REMARK 465 GLU B 131 REMARK 465 ARG B 132 REMARK 465 THR B 133 REMARK 465 GLY B 134 REMARK 465 THR B 135 REMARK 465 GLN B 136 REMARK 465 PRO B 137 REMARK 465 LEU B 138 REMARK 465 GLY B 139 REMARK 465 VAL B 140 REMARK 465 GLN B 141 REMARK 465 SER B 180 REMARK 465 GLY B 181 REMARK 465 CYS B 182 REMARK 465 GLU B 183 REMARK 465 LEU B 184 REMARK 465 PRO B 185 REMARK 465 GLU B 186 REMARK 465 SER B 187 REMARK 465 LEU B 188 REMARK 465 GLN B 189 REMARK 465 ALA B 190 REMARK 465 PRO B 191 REMARK 465 SER B 192 REMARK 465 ARG B 193 REMARK 465 GLU B 194 REMARK 465 ASP B 310 REMARK 465 THR B 311 REMARK 465 ALA B 312 REMARK 465 GLY B 313 REMARK 465 GLY B 314 REMARK 465 PHE B 315 REMARK 465 GLY B 433 REMARK 465 SER B 434 REMARK 465 SER B 435 REMARK 465 SER B 436 REMARK 465 SER B 437 REMARK 465 GLY B 438 REMARK 465 GLY B 439 REMARK 465 THR B 440 REMARK 465 CYS B 441 REMARK 465 PRO B 442 REMARK 465 SER B 443 REMARK 465 SER B 444 REMARK 465 HIS B 445 REMARK 465 SER B 446 REMARK 465 SER B 447 REMARK 465 GLU B 461 REMARK 465 GLY B 462 REMARK 465 SER B 463 REMARK 465 PRO B 464 REMARK 465 SER B 465 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ARG A 152 CG CD NE CZ NH1 NH2 REMARK 470 ARG A 203 CG CD NE CZ NH1 NH2 REMARK 470 LYS A 210 CG CD CE NZ REMARK 470 GLU A 218 CG CD OE1 OE2 REMARK 470 LYS A 234 CG CD CE NZ REMARK 470 ARG A 303 CG CD NE CZ NH1 NH2 REMARK 470 GLU A 309 CG CD OE1 OE2 REMARK 470 LEU A 320 CG CD1 CD2 REMARK 470 GLN A 383 CG CD OE1 NE2 REMARK 470 THR A 432 OG1 CG2 REMARK 470 GLU A 450 CG CD OE1 OE2 REMARK 470 GLN A 460 CG CD OE1 NE2 REMARK 470 LYS B 204 CG CD CE NZ REMARK 470 GLU B 218 CG CD OE1 OE2 REMARK 470 SER B 231 OG REMARK 470 LYS B 234 CG CD CE NZ REMARK 470 LEU B 308 CG CD1 CD2 REMARK 470 GLN B 316 CG CD OE1 NE2 REMARK 470 GLN B 317 CG CD OE1 NE2 REMARK 470 LEU B 318 CG CD1 CD2 REMARK 470 GLN B 409 CG CD OE1 NE2 REMARK 470 GLU B 450 CG CD OE1 OE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O LEU A 209 O9 G3L A 601 1.72 REMARK 500 O ASP B 205 OG SER B 208 2.07 REMARK 500 NE2 GLN A 285 O3 G3L A 601 2.10 REMARK 500 OG SER A 247 O1 G3L A 601 2.16 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 PRO A 382 C - N - CA ANGL. DEV. = 11.5 DEGREES REMARK 500 PRO A 384 C - N - CA ANGL. DEV. = -10.9 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 230 -159.53 -72.37 REMARK 500 SER A 231 28.88 -179.27 REMARK 500 CYS A 301 74.74 -109.99 REMARK 500 PHE A 349 45.13 -94.25 REMARK 500 ASP A 352 32.37 -93.70 REMARK 500 PRO A 382 50.30 -35.81 REMARK 500 GLN A 383 -103.17 44.15 REMARK 500 ALA A 385 -32.42 77.79 REMARK 500 PHE A 420 -21.09 -145.62 REMARK 500 HIS A 452 56.61 -140.61 REMARK 500 GLU B 218 11.90 -63.18 REMARK 500 ASP B 230 -154.67 -92.77 REMARK 500 SER B 231 83.48 -178.57 REMARK 500 LYS B 234 -0.80 -57.13 REMARK 500 CYS B 301 66.12 -107.83 REMARK 500 PHE B 349 54.06 -91.17 REMARK 500 HIS B 418 86.99 -154.60 REMARK 500 PHE B 420 -19.00 -158.25 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: MAIN CHAIN PLANARITY REMARK 500 REMARK 500 THE FOLLOWING RESIDUES HAVE A PSEUDO PLANARITY REMARK 500 TORSION ANGLE, C(I) - CA(I) - N(I+1) - O(I), GREATER REMARK 500 10.0 DEGREES. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 500 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 500 I=INSERTION CODE). REMARK 500 REMARK 500 M RES CSSEQI ANGLE REMARK 500 GLU A 145 -12.50 REMARK 500 SER A 447 -12.01 REMARK 500 GLU B 195 -11.68 REMARK 500 SER B 208 11.41 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue G3L A 601 DBREF 7CHG A 130 434 UNP O75469 NR1I2_HUMAN 130 434 DBREF 7CHG A 441 465 UNP Q15788 NCOA1_HUMAN 676 700 DBREF 7CHG B 130 434 UNP O75469 NR1I2_HUMAN 130 434 DBREF 7CHG B 441 465 UNP Q15788 NCOA1_HUMAN 676 700 SEQADV 7CHG MET A 129 UNP O75469 INITIATING METHIONINE SEQADV 7CHG SER A 435 UNP O75469 LINKER SEQADV 7CHG SER A 436 UNP O75469 LINKER SEQADV 7CHG SER A 437 UNP O75469 LINKER SEQADV 7CHG GLY A 438 UNP O75469 LINKER SEQADV 7CHG GLY A 439 UNP O75469 LINKER SEQADV 7CHG THR A 440 UNP O75469 LINKER SEQADV 7CHG MET B 129 UNP O75469 INITIATING METHIONINE SEQADV 7CHG SER B 435 UNP O75469 LINKER SEQADV 7CHG SER B 436 UNP O75469 LINKER SEQADV 7CHG SER B 437 UNP O75469 LINKER SEQADV 7CHG GLY B 438 UNP O75469 LINKER SEQADV 7CHG GLY B 439 UNP O75469 LINKER SEQADV 7CHG THR B 440 UNP O75469 LINKER SEQRES 1 A 337 MET SER GLU ARG THR GLY THR GLN PRO LEU GLY VAL GLN SEQRES 2 A 337 GLY LEU THR GLU GLU GLN ARG MET MET ILE ARG GLU LEU SEQRES 3 A 337 MET ASP ALA GLN MET LYS THR PHE ASP THR THR PHE SER SEQRES 4 A 337 HIS PHE LYS ASN PHE ARG LEU PRO GLY VAL LEU SER SER SEQRES 5 A 337 GLY CYS GLU LEU PRO GLU SER LEU GLN ALA PRO SER ARG SEQRES 6 A 337 GLU GLU ALA ALA LYS TRP SER GLN VAL ARG LYS ASP LEU SEQRES 7 A 337 CYS SER LEU LYS VAL SER LEU GLN LEU ARG GLY GLU ASP SEQRES 8 A 337 GLY SER VAL TRP ASN TYR LYS PRO PRO ALA ASP SER GLY SEQRES 9 A 337 GLY LYS GLU ILE PHE SER LEU LEU PRO HIS MET ALA ASP SEQRES 10 A 337 MET SER THR TYR MET PHE LYS GLY ILE ILE SER PHE ALA SEQRES 11 A 337 LYS VAL ILE SER TYR PHE ARG ASP LEU PRO ILE GLU ASP SEQRES 12 A 337 GLN ILE SER LEU LEU LYS GLY ALA ALA PHE GLU LEU CYS SEQRES 13 A 337 GLN LEU ARG PHE ASN THR VAL PHE ASN ALA GLU THR GLY SEQRES 14 A 337 THR TRP GLU CYS GLY ARG LEU SER TYR CYS LEU GLU ASP SEQRES 15 A 337 THR ALA GLY GLY PHE GLN GLN LEU LEU LEU GLU PRO MET SEQRES 16 A 337 LEU LYS PHE HIS TYR MET LEU LYS LYS LEU GLN LEU HIS SEQRES 17 A 337 GLU GLU GLU TYR VAL LEU MET GLN ALA ILE SER LEU PHE SEQRES 18 A 337 SER PRO ASP ARG PRO GLY VAL LEU GLN HIS ARG VAL VAL SEQRES 19 A 337 ASP GLN LEU GLN GLU GLN PHE ALA ILE THR LEU LYS SER SEQRES 20 A 337 TYR ILE GLU CYS ASN ARG PRO GLN PRO ALA HIS ARG PHE SEQRES 21 A 337 LEU PHE LEU LYS ILE MET ALA MET LEU THR GLU LEU ARG SEQRES 22 A 337 SER ILE ASN ALA GLN HIS THR GLN ARG LEU LEU ARG ILE SEQRES 23 A 337 GLN ASP ILE HIS PRO PHE ALA THR PRO LEU MET GLN GLU SEQRES 24 A 337 LEU PHE GLY ILE THR GLY SER SER SER SER GLY GLY THR SEQRES 25 A 337 CYS PRO SER SER HIS SER SER LEU THR GLU ARG HIS LYS SEQRES 26 A 337 ILE LEU HIS ARG LEU LEU GLN GLU GLY SER PRO SER SEQRES 1 B 337 MET SER GLU ARG THR GLY THR GLN PRO LEU GLY VAL GLN SEQRES 2 B 337 GLY LEU THR GLU GLU GLN ARG MET MET ILE ARG GLU LEU SEQRES 3 B 337 MET ASP ALA GLN MET LYS THR PHE ASP THR THR PHE SER SEQRES 4 B 337 HIS PHE LYS ASN PHE ARG LEU PRO GLY VAL LEU SER SER SEQRES 5 B 337 GLY CYS GLU LEU PRO GLU SER LEU GLN ALA PRO SER ARG SEQRES 6 B 337 GLU GLU ALA ALA LYS TRP SER GLN VAL ARG LYS ASP LEU SEQRES 7 B 337 CYS SER LEU LYS VAL SER LEU GLN LEU ARG GLY GLU ASP SEQRES 8 B 337 GLY SER VAL TRP ASN TYR LYS PRO PRO ALA ASP SER GLY SEQRES 9 B 337 GLY LYS GLU ILE PHE SER LEU LEU PRO HIS MET ALA ASP SEQRES 10 B 337 MET SER THR TYR MET PHE LYS GLY ILE ILE SER PHE ALA SEQRES 11 B 337 LYS VAL ILE SER TYR PHE ARG ASP LEU PRO ILE GLU ASP SEQRES 12 B 337 GLN ILE SER LEU LEU LYS GLY ALA ALA PHE GLU LEU CYS SEQRES 13 B 337 GLN LEU ARG PHE ASN THR VAL PHE ASN ALA GLU THR GLY SEQRES 14 B 337 THR TRP GLU CYS GLY ARG LEU SER TYR CYS LEU GLU ASP SEQRES 15 B 337 THR ALA GLY GLY PHE GLN GLN LEU LEU LEU GLU PRO MET SEQRES 16 B 337 LEU LYS PHE HIS TYR MET LEU LYS LYS LEU GLN LEU HIS SEQRES 17 B 337 GLU GLU GLU TYR VAL LEU MET GLN ALA ILE SER LEU PHE SEQRES 18 B 337 SER PRO ASP ARG PRO GLY VAL LEU GLN HIS ARG VAL VAL SEQRES 19 B 337 ASP GLN LEU GLN GLU GLN PHE ALA ILE THR LEU LYS SER SEQRES 20 B 337 TYR ILE GLU CYS ASN ARG PRO GLN PRO ALA HIS ARG PHE SEQRES 21 B 337 LEU PHE LEU LYS ILE MET ALA MET LEU THR GLU LEU ARG SEQRES 22 B 337 SER ILE ASN ALA GLN HIS THR GLN ARG LEU LEU ARG ILE SEQRES 23 B 337 GLN ASP ILE HIS PRO PHE ALA THR PRO LEU MET GLN GLU SEQRES 24 B 337 LEU PHE GLY ILE THR GLY SER SER SER SER GLY GLY THR SEQRES 25 B 337 CYS PRO SER SER HIS SER SER LEU THR GLU ARG HIS LYS SEQRES 26 B 337 ILE LEU HIS ARG LEU LEU GLN GLU GLY SER PRO SER HET G3L A 601 37 HETNAM G3L NOMILIN HETSYN G3L [(1R,2R,4S,7S,8S,11R,12R,13S,18R)-7-(FURAN-3-YL)-1,8, HETSYN 2 G3L 12,17,17-PENTAMETHYL-5,15,20-TRIOXO-3,6,16- HETSYN 3 G3L TRIOXAPENTACYCLO[9.9.0.02,4.02,8.012,18]ICOSAN-13-YL] HETSYN 4 G3L ACETATE FORMUL 3 G3L C28 H34 O9 FORMUL 4 HOH *166(H2 O) HELIX 1 AA1 THR A 144 PHE A 162 1 19 HELIX 2 AA2 GLU A 194 SER A 208 1 15 HELIX 3 AA3 GLY A 233 SER A 238 5 6 HELIX 4 AA4 LEU A 239 ILE A 261 1 23 HELIX 5 AA5 ILE A 261 ASP A 266 1 6 HELIX 6 AA6 PRO A 268 VAL A 291 1 24 HELIX 7 AA7 GLU A 321 LEU A 333 1 13 HELIX 8 AA8 HIS A 336 PHE A 349 1 14 HELIX 9 AA9 GLN A 358 ARG A 381 1 24 HELIX 10 AB1 PHE A 388 HIS A 418 1 31 HELIX 11 AB2 THR A 422 GLY A 430 1 9 HELIX 12 AB3 HIS A 452 GLN A 460 1 9 HELIX 13 AB4 THR B 144 PHE B 162 1 19 HELIX 14 AB5 ALA B 196 SER B 208 1 13 HELIX 15 AB6 GLY B 233 PHE B 237 5 5 HELIX 16 AB7 LEU B 239 ILE B 261 1 23 HELIX 17 AB8 ILE B 261 ASP B 266 1 6 HELIX 18 AB9 PRO B 268 VAL B 291 1 24 HELIX 19 AC1 GLN B 317 LEU B 320 5 4 HELIX 20 AC2 GLU B 321 LEU B 333 1 13 HELIX 21 AC3 HIS B 336 PHE B 349 1 14 HELIX 22 AC4 GLN B 358 ARG B 381 1 24 HELIX 23 AC5 GLN B 383 ARG B 387 5 5 HELIX 24 AC6 PHE B 388 HIS B 418 1 31 HELIX 25 AC7 THR B 422 GLY B 430 1 9 HELIX 26 AC8 HIS B 452 GLN B 460 1 9 SHEET 1 AA110 PHE A 292 ASN A 293 0 SHEET 2 AA110 THR A 298 CYS A 301 -1 O THR A 298 N ASN A 293 SHEET 3 AA110 LEU A 304 CYS A 307 -1 O TYR A 306 N TRP A 299 SHEET 4 AA110 SER A 212 ARG A 216 -1 N SER A 212 O CYS A 307 SHEET 5 AA110 VAL A 222 LYS A 226 -1 O TRP A 223 N LEU A 215 SHEET 6 AA110 VAL B 222 LYS B 226 -1 O ASN B 224 N ASN A 224 SHEET 7 AA110 VAL B 211 ARG B 216 -1 N LEU B 213 O TYR B 225 SHEET 8 AA110 LEU B 304 LEU B 308 -1 O CYS B 307 N SER B 212 SHEET 9 AA110 THR B 298 CYS B 301 -1 N TRP B 299 O TYR B 306 SHEET 10 AA110 PHE B 292 ASN B 293 -1 N ASN B 293 O THR B 298 SITE 1 AC1 15 LEU A 209 VAL A 211 LEU A 240 MET A 243 SITE 2 AC1 15 SER A 247 PHE A 251 PHE A 281 GLN A 285 SITE 3 AC1 15 PHE A 288 TRP A 299 HIS A 327 HIS A 407 SITE 4 AC1 15 LEU A 411 PHE A 420 PHE A 429 CRYST1 84.930 90.109 106.341 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.011774 0.000000 0.000000 0.00000 SCALE2 0.000000 0.011098 0.000000 0.00000 SCALE3 0.000000 0.000000 0.009404 0.00000